DACOMITINIB | DACOMITINIB | ATC L01XE47
ANTINEOPLASTIC IRREVERSIBLE KINASE INHIBITOR OF EGFR FAMILY (EGFR/HER1, HER2 AND HER4) COMPLEX PDB 4I23 TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) ALSO INHIBITED THE ACTIVITY OF DDR1, EPHA6, LCK, DDR2, AND MNK1 AT CLINICALLY RELEVANT CONCENTRATIONS | ORAL | Cmax 230 NANOMOLAR Tmax 6 HOUR F 80 PERCENT VD 1889 LITER PPB 98 PERCENT Cl 24.9 LITER / HOUR HT 70 HOUR | EGFR KINASE | Epidermal growth factor receptor P00533 | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |